VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 107 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 5.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,294 | +7.4% | 34,440 | 0.0% | 0.00% | – |
| Q4 2022 | $4,000 | -33.3% | 34,440 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | -83.3% | 34,440 | -15.4% | 0.00% | – |
| Q2 2022 | $36,000 | -12.2% | 40,709 | +24.1% | 0.00% | – |
| Q1 2022 | $41,000 | -50.6% | 32,809 | -23.2% | 0.00% | – |
| Q4 2021 | $83,000 | +2.5% | 42,696 | +45.0% | 0.00% | – |
| Q3 2021 | $81,000 | +84.1% | 29,441 | +110.7% | 0.00% | – |
| Q2 2021 | $44,000 | -87.9% | 13,971 | -91.8% | 0.00% | -100.0% |
| Q1 2021 | $365,000 | +9.6% | 171,414 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $333,000 | +179.8% | 171,414 | 0.0% | 0.00% | – |
| Q3 2020 | $119,000 | +32.2% | 171,414 | 0.0% | 0.00% | – |
| Q2 2020 | $90,000 | +20.0% | 171,414 | 0.0% | 0.00% | – |
| Q1 2020 | $75,000 | – | 171,414 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $32,135,000 | 11.34% |
| VR Adviser, LLC | 16,047,286 | $43,970,000 | 5.65% |
| COMMODORE CAPITAL LP | 5,123,509 | $14,038,000 | 3.70% |
| Ghost Tree Capital, LLC | 2,000,000 | $5,480,000 | 1.60% |
| EPIQ PARTNERS, LLC | 916,100 | $2,510,000 | 1.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 707,733 | $1,939,000 | 1.10% |
| SPHERA FUNDS MANAGEMENT LTD. | 3,824,938 | $10,480,000 | 0.88% |
| HighVista Strategies LLC | 438,239 | $1,201,000 | 0.80% |
| Nicholas Investment Partners, LP | 2,786,354 | $7,635,000 | 0.56% |
| NEA Management Company, LLC | 16,302,596 | $44,669,000 | 0.53% |